China’s Role in the Fentanyl Crisis: Insights from Sebastian Gorka
In a recent interview, Sebastian Gorka, President Trump’s counterterrorism director, suggested that China is deliberately sending large quantities of fentanyl into the U.S. He described this as part of an ongoing “opium war” targeting American citizens.
Gorka shared these views during a “Pod Force One” chat with Miranda Devine from the Post, just before Trump was set to leave for a state visit to Beijing focused on trade.
“They view our country as a modern British Empire. Maybe this is their way of seeking revenge for historical opium conflicts. Many are echoing this sentiment, and I think there’s validity to it,” Gorka remarked.
He compared the situation to the biblical story of David and Goliath, asserting that fentanyl serves as a “slingshot” against the U.S.
The historical Opium Wars reference isn’t new and has been used by Congressional Republicans to draw parallels between today’s fentanyl crisis and the 19th-century conflicts where British and French forces compelled China to permit opium imports, leading to widespread addiction and societal upheaval.
Fentanyl, primarily sourced from China, has resulted in approximately 403,000 U.S. deaths over the past seven years, as reported by the Centers for Disease Control and Prevention.
Gorka emphasized, “China is behind the precursors for these mass destruction weapons.” He further stated, “This isn’t just a drug problem causing accidental deaths; this is a targeted assault on Americans.” He expressed concern over the distribution of pills disguised as recreational drugs, which could contain lethal doses of fentanyl.
“It’s a form of warfare, but a different kind,” he said.
The statistic indicating that one in 850 Americans have died from synthetic opioids over seven years highlights the gravity of the crisis, with many users unknowingly consuming drugs mixed with fentanyl. Just a tiny amount of the substance can result in fatal respiratory failure.
It remains uncertain how Gorka’s strong statements will influence Trump’s upcoming meeting in Beijing. Historically, Chinese officials have pushed back against accusations of responsibility, arguing that fentanyl remains a U.S. problem, and they tout their anti-drug efforts.
The Chinese Foreign Ministry previously claimed to have collaborated extensively with the U.S. on drug-related issues, achieving notable success. While incidences of fentanyl-related deaths might reach a peak this year and have shown signs of decline, the reasons remain hotly debated among experts.
Trump has condemned China’s exportation of fentanyl. Since taking office, he’s initiated a 20% tariff on all Chinese imports, aiming to compel the nation to take action against smuggling. This was later reduced to 10% after a private assurance from President Xi Jinping at a summit.
Recent actions from the Supreme Court reversed Trump’s tariffs, creating financial obligations for companies affected by these fees, amounting to at least $166 billion.
Despite claims from China about improved export controls, the drop in addiction-related deaths might also stem from stricter U.S. and Mexican border regulations, greater access to drug test kits and overdose prevention medications, and a decrease in the potential victim pool.
Nonetheless, around 39,000 Americans died in just the past year due to fentanyl, suggesting that fatalities remain above pre-pandemic levels, a time that saw U.S.-China relations become increasingly strained.
In discussions leading up to meetings with Xi, Trump noted, “It’s about fentanyl.” He pointed out that China has been “losing” financially due to tariffs, highlighting that illegal fentanyl sales in the U.S. are incredibly profitable.
Gorka’s remarks and Trump’s approach underscore a growing tension as the U.S. continues to grapple with the devastation caused by fentanyl flowing into the country.
